Bilateral congenital renal agenesis is a rare and life-threatening congenital condition in which both kidneys fail to develop during fetal growth in the womb. This condition raises many questions among families regarding its causes, its impact on the newborn’s health, and the chances of survival after birth. The severity of this condition is not limited to the absence of both kidneys and their vital functions; it also extends to its impact on lung development due to a severe reduction in the amniotic fluid surrounding the fetus, which may lead to severe breathing difficulties after birth. In this Dilely Medical article, we highlight the most important information about bilateral congenital renal agenesis, explain the causes of respiratory complications, discuss diagnostic methods and available medical treatment options, and explore the factors that influence survival chances, while emphasizing the importance of specialized medical care and family support in managing this condition.
Bilateral congenital renal agenesis is defined as the failure of both kidneys to develop in the fetus during the stages of growth inside the womb. This condition differs from cases in which both kidneys are present but are abnormally small or have impaired function.
The severity of this condition stems from the absence of both kidneys, which are responsible for filtering waste products from the blood and regulating fluid and electrolyte balance in the body. In addition, the absence of fetal urine production leads to a severe reduction in the surrounding amniotic fluid. This may interfere with normal lung development and cause pulmonary hypoplasia, which can result in severe respiratory difficulties after birth.
Yes. In some cases, bilateral congenital renal agenesis may be associated with genetic changes or inherited syndromes that affect the development of the urinary system. In other cases, no specific genetic cause can be identified.
Therefore, genetic counseling may be beneficial, particularly when there is a family history of similar cases or a suspected genetic disorder.
This condition may be suspected during pregnancy through ultrasound imaging, which may reveal the absence of both kidneys and a reduced amount of amniotic fluid. Confirming the diagnosis requires a specialized medical assessment, with additional investigations when necessary.
After birth, abdominal ultrasound is used to verify the absence of both kidneys and rule out other conditions that may present similarly.
Yes. In some cases, the kidneys may be difficult to identify clearly during ultrasound examination because of the fetus's position or certain technical factors. Other conditions, such as abnormally positioned or extremely small kidneys, may also lead to a suspicion that the kidneys are absent.
Therefore, a thorough assessment by a specialized medical team is essential to distinguish between these conditions and establish an accurate diagnosis.
Bilateral congenital renal agenesis may occur alongside other congenital abnormalities affecting the urinary system, heart, skeletal system, and nervous system.
The presence and severity of these abnormalities vary from one case to another. They may be associated with genetic disorders or accompanying congenital syndromes. Therefore, a comprehensive medical evaluation is essential to determine the nature of the condition and identify any related health problems.
The prognosis for bilateral congenital renal agenesis is extremely serious, particularly when severe pulmonary hypoplasia develops because of a profound reduction in amniotic fluid during pregnancy. These complications may result in fetal death before birth or neonatal death shortly after delivery due to respiratory failure.
However, in recent years, specialized prenatal treatment approaches have been attempted, allowing a limited number of infants to survive. These interventions remain limited in their application and do not guarantee survival. Outcomes depend on several factors, including the degree of lung development and the newborn's overall health.
Breathing difficulties in these cases are primarily caused by a prolonged reduction in amniotic fluid during pregnancy due to the absence of fetal urine production. This adversely affects lung growth and development, potentially resulting in a condition known as pulmonary hypoplasia, in which the lungs do not develop sufficiently or reach the size needed to function normally.
Consequently, the newborn may experience severe respiratory impairment after birth, requiring urgent assessment and appropriate respiratory support according to the infant's condition.
In cases of complete bilateral renal agenesis, the body cannot produce urine through the kidneys because both kidneys are entirely absent. Therefore, normal urination is not expected in a newborn affected by this condition.
The absence of urine output is an important clinical finding that may help the medical team assess the baby's condition. However, it is not sufficient on its own to confirm the diagnosis. It must be interpreted alongside the clinical examination, imaging results, and other necessary investigations.
It is not possible to determine the degree of pain or discomfort experienced by every newborn with bilateral congenital renal agenesis, as this depends on the infant’s clinical condition, the extent of respiratory impairment, and the presence of other complications.
The medical team carefully assesses signs of pain and distress in the newborn and provides appropriate measures to relieve suffering and improve comfort. When the condition is life-threatening and no treatment options are available that can achieve recovery, specialized neonatal palliative care may be provided to relieve breathing difficulties and potential pain while offering the necessary support to the family.
Currently, no treatment can recreate kidneys that failed to develop during fetal growth. Although dialysis and kidney transplantation may be used to replace kidney function in selected cases of kidney failure, they do not treat pulmonary hypoplasia resulting from reduced amniotic fluid during pregnancy.
Dialysis may replace some of the functions normally performed by the kidneys by helping remove waste products and regulate fluid and electrolyte balance in the body. However, dialysis does not treat underdeveloped lungs caused by reduced amniotic fluid during pregnancy.
In cases of complete bilateral renal agenesis, the feasibility of dialysis depends on several factors, including respiratory function, the newborn’s overall health, and the availability of specialized medical resources.
Therefore, any decision regarding dialysis requires a thorough assessment by a multidisciplinary medical team, taking into account the potential benefits of treatment and the challenges associated with it.
Care for a newborn with bilateral congenital renal agenesis depends on the infant’s clinical condition, the extent to which organ functions are affected, and the severity of pulmonary hypoplasia. Medical care may include several measures, such as:
Respiratory assessment: Monitoring breathing and oxygen levels and determining whether respiratory function is adequate.
Respiratory support: Providing appropriate breathing support according to the newborn’s condition and needs.
Evaluation of treatment options: Assessing the feasibility of specialized medical interventions and discussing their benefits, risks, and limitations with the family.
Supportive and palliative care: Relieving pain and breathing difficulties, promoting the baby’s comfort, and providing psychological and emotional support to the family, particularly when the chances of recovery are limited.
As the fetus continues to develop, the absence of both kidneys results in a lack of fetal urine production. This becomes particularly significant during the second half of pregnancy, when fetal urine becomes the primary source of the surrounding amniotic fluid.
Amniotic fluid plays an essential role in supporting lung development and allowing fetal movement. Consequently, the absence of fetal urine can lead to a severe reduction in amniotic fluid, potentially impairing normal lung development and contributing to pulmonary hypoplasia.
The goal of an individualized care plan is to achieve the best possible level of comfort and quality of care while taking into account the baby’s medical condition and the family’s needs.
Neonatal palliative care is a medical and compassionate approach aimed at relieving suffering and improving the comfort of infants with serious medical conditions while providing psychological and social support to their families.
This type of care does not mean abandoning the baby or neglecting their needs. Instead, it focuses on relieving pain, breathing difficulties, and discomfort, creating an environment that promotes the infant’s comfort, and helping the family understand the condition and make informed decisions about care.
The palliative care plan is developed collaboratively by the medical team and the family, taking into account the newborn’s clinical condition, the agreed-upon goals of care, and the available medical options.
Yes. The condition can recur in some future pregnancies, although the likelihood varies depending on the underlying cause, particularly when genetic changes or hereditary disorders affecting kidney development are present.
Genetic counseling is an important step in assessing the risk of recurrence, identifying appropriate tests before or during pregnancy, and developing a plan for early ultrasound monitoring when necessary. Identifying the possible cause of the condition helps provide the family with more accurate information about future pregnancies.
Not all congenital abnormalities can be prevented, and the occurrence of bilateral congenital renal agenesis does not mean that the mother did anything wrong or failed to take proper care of her pregnancy.
This condition may arise from abnormalities in fetal development and, in some cases, may be associated with genetic factors that cannot be prevented.
Bilateral renal agenesis is a rare congenital defect characterized by the failure of both kidneys to develop during fetal growth in the womb. It is important to note that this condition is not classified into formally established disease stages. Instead, its development and effects during pregnancy and after birth can be explained through a sequence of stages.
This stage begins during the early weeks of embryonic development, when abnormalities occur in the embryological processes responsible for kidney formation, including the interaction between the ureteric bud and the metanephric mesenchyme.
As a result, the kidneys fail to develop normally and may be completely absent.
As a result of absent fetal urine production, the amount of amniotic fluid decreases significantly and may become almost completely absent, a condition known as anhydramnios. This finding can be detected during pregnancy through ultrasound imaging, which may also reveal the absence of both kidneys and the lack of urine in the bladder.
Persistent oligohydramnios can lead to complications that affect fetal development. The most notable include:
Pulmonary hypoplasia: Incomplete lung development, which may result in severe respiratory failure after birth.
Structural abnormalities: Certain facial features or limb deformities may develop because of prolonged intrauterine compression and reduced amniotic fluid.
Potter sequence: A group of abnormalities and complications resulting from severe oligohydramnios, potentially including pulmonary hypoplasia and characteristic physical changes.
If the baby is born alive, serious complications may occur, particularly breathing difficulties caused by underdeveloped lungs and the absence of urine production due to the complete absence of both kidneys.
In severe cases, the prognosis is extremely poor, especially when pulmonary hypoplasia is profound. Care is determined by the newborn’s condition and may include respiratory support, assessment of specialized treatment options, and palliative care when needed to relieve suffering and promote the infant’s comfort.
Bilateral congenital renal agenesis is a rare congenital defect that occurs when both kidneys fail to develop during embryonic development. It may be associated with the absence of both ureters and a severe reduction in amniotic fluid. Several mechanisms may contribute to this condition, including abnormalities in embryonic development and genetic or hereditary factors. However, the exact cause remains unidentified in some cases.
Bilateral congenital renal agenesis results from abnormalities in the processes responsible for the formation of the urinary system during the early stages of fetal development. The main possible mechanisms include:
Failure of ureteric bud formation: The ureteric bud is an essential embryonic structure that contributes to the development of the kidney's collecting system, including the ureter, renal pelvis, and collecting ducts.
Disruption of the interaction between the ureteric bud and the metanephric mesenchyme: This interaction is essential for initiating normal kidney formation and development. Disruption of this process may prevent the kidneys from developing.
Abnormal molecular signaling involved in kidney development: Changes affecting the molecular pathways responsible for renal tissue growth and differentiation may interfere with normal kidney development.
Bilateral congenital renal agenesis may be associated with genetic changes that affect kidney development and the formation of the urinary system. Genes associated with certain cases of abnormal kidney development include:
RET
GDNF
GFRA1
ITGA8
GREB1L
FRAS1 and FREM2, which may be associated with certain congenital syndromes involving kidney abnormalities and abnormalities in other organ systems.
This list does not mean that all cases result from changes in these genes. The condition may occur as part of a recognized genetic disorder or as an isolated abnormality without an identifiable genetic cause.
Genetic factors may contribute to bilateral congenital renal agenesis. Their assessment becomes particularly important when there is a family history of similar cases or congenital abnormalities of the urinary system.
Genetic changes may be inherited from one or both parents or arise as new changes in the fetus. The inheritance pattern varies depending on the gene and the associated disorder. Therefore, genetic counseling is recommended when a genetic cause is suspected to help estimate the risk of recurrence in future pregnancies.
Some congenital kidney abnormalities may be associated with maternal or environmental factors. However, no single environmental factor has been established as the explanation for most cases of bilateral congenital renal agenesis.
In many cases, doctors cannot determine the exact cause, even after the available investigations have been performed.
The absence of both kidneys results in a lack of fetal urine production. During the second half of pregnancy, fetal urine is the primary source of amniotic fluid. Consequently, severe oligohydramnios or anhydramnios may develop, affecting lung development and potentially causing pulmonary hypoplasia.
A reduction in amniotic fluid may also cause structural changes due to intrauterine compression, such as a flattened nose, a recessed chin, and abnormal limb positioning. A group of these changes is known as Potter sequence.
The signs associated with bilateral congenital renal agenesis vary according to when the condition is detected and the severity of its complications. Initial indicators may appear during pregnancy, while some complications become apparent after birth if the baby is born alive.
The main findings that may raise suspicion of this condition include:
Severe oligohydramnios or anhydramnios: This occurs because fetal urine production is absent, even though urine normally contributes substantially to amniotic fluid formation during the second half of pregnancy.
Failure to visualize the kidneys on ultrasound: Imaging may show that both kidneys are absent from their normal anatomical locations. Specialized assessment is required to rule out similar conditions.
Failure of the urinary bladder to fill: The bladder may not appear to contain urine during ultrasound examination. This finding supports suspicion of the condition but is not sufficient to confirm the diagnosis on its own.
Pulmonary hypoplasia: This may develop when amniotic fluid remains severely reduced during a critical period of lung development.
Fetal structural changes: These may occur because of prolonged intrauterine compression associated with a severe reduction in amniotic fluid.
If the baby is born alive, signs and complications related to the absence of both kidneys and underdeveloped lungs may become apparent. The most notable include:
Severe breathing difficulties: These result from pulmonary hypoplasia and may represent one of the most serious early complications.
Anuria: The complete absence of urine production because both kidneys, which normally produce urine, are absent.
Characteristic facial features: These may include a flattened nose, a recessed chin, and low-set ears, which can be associated with Potter sequence.
Abnormal limb positioning: Certain deformities or abnormal limb positions may occur because of intrauterine compression and reduced amniotic fluid.
Associated congenital abnormalities: Abnormalities of the reproductive system or other organ systems may also be present, depending on the nature of the condition and any associated disorders.
The main complications associated with bilateral congenital renal agenesis include:
Pulmonary hypoplasia: This may lead to severe respiratory failure after birth.
Complete absence of kidney function: This results in a lack of urine production and the inability to eliminate waste products or regulate fluid and electrolyte balance normally.
Death before or after birth: This may occur in severe cases, particularly when pulmonary hypoplasia is profound.
It is important to note that bilateral congenital renal agenesis does not progress through formally established disease stages. Instead, the findings described above represent a sequence of possible effects and complications resulting from the absence of both kidneys during fetal development. The severity of these findings varies from one case to another, and the diagnosis must be confirmed through specialized medical evaluation.
Bilateral congenital renal agenesis is a rare congenital abnormality characterized by the failure of both kidneys to develop during fetal growth. Diagnosis relies primarily on prenatal imaging, particularly ultrasound, with additional investigations performed when necessary.
Ultrasound is the primary examination used to detect bilateral congenital renal agenesis. It may reveal the following findings:
Absence of both kidneys: The kidneys cannot be visualized in their normal anatomical positions on either side of the spine.
Absent or unfilled urinary bladder: This occurs because fetal urine production is absent.
Severe oligohydramnios or anhydramnios: This refers to a severely reduced or completely absent amount of amniotic fluid.
Difficulty assessing certain anatomical structures: A severe reduction in amniotic fluid may limit the clarity of ultrasound images.
Color Doppler ultrasound may be used to assess the renal blood vessels. Failure to visualize the renal arteries may support suspicion of bilateral renal agenesis. However, this finding alone is insufficient to confirm the diagnosis and must be interpreted alongside other examination results.
A detailed examination performed by a maternal-fetal medicine specialist may help confirm the absence of both kidneys and determine whether they are located in abnormal anatomical positions, such as the pelvis.
This examination also helps distinguish true renal agenesis from other kidney abnormalities that may have a similar appearance.
Fetal MRI may be considered when ultrasound findings are inconclusive. It provides a more detailed assessment of fetal anatomy and may help confirm the absence of both kidneys or rule out kidneys located in abnormal positions.
MRI is a supplementary diagnostic examination and is not necessary in every case.
If the baby is born alive, the following investigations may be used to confirm the diagnosis and assess the infant's health:
Abdominal ultrasound: Used to verify the absence of both kidneys and assess the urinary bladder and surrounding anatomical structures.
Computed tomography (CT) or magnetic resonance imaging (MRI): Either may be considered when necessary if ultrasound findings are insufficient to confirm the diagnosis.
Clinical examination: Includes assessing the infant's respiratory condition and looking for features associated with Potter sequence, which may occur following severe oligohydramnios during pregnancy.
Genetic testing: May be recommended when a hereditary cause is suspected or when renal agenesis occurs alongside other congenital abnormalities.
Bilateral congenital renal agenesis must be distinguished from other conditions that may produce similar imaging findings. The most important include:
1. Ectopic kidney: The kidney is present but located in an abnormal anatomical position, such as the pelvis, rather than its usual location.
2. Bilateral renal dysplasia: Both kidneys are present, but their tissues and anatomical structures have developed abnormally.
3. Polycystic kidney disease: The kidneys may appear enlarged and have increased echogenicity on ultrasound. They may also contain multiple cysts, depending on the type and severity of the disease.
4. Severe lower urinary tract obstruction: This may cause abnormalities involving the bladder and kidneys and may be associated with reduced amniotic fluid. However, it differs from true renal agenesis because the organs are present but affected by pathological changes.
There are currently no medications capable of treating bilateral congenital renal agenesis or stimulating the formation of kidneys that failed to develop during embryonic development.
Medical interventions focus on managing complications and attempting to support vital functions, depending on the condition of the fetus or newborn.
|
Medication or intervention |
Therapeutic role |
|---|---|
|
Antibiotics |
Used to treat bacterial infections when they occur or to prevent them in specific circumstances, but they do not treat renal agenesis. |
|
Medications supporting blood pressure and circulation |
May be used in intensive care when necessary, depending on the newborn's clinical condition. |
|
Respiratory support medications |
May be included in a respiratory support plan, but they do not correct pulmonary hypoplasia caused by reduced amniotic fluid. |
|
Dialysis |
Not a medication, but it may help remove waste products and excess fluid and replace some kidney functions after birth if the infant's condition permits. |
|
Kidney transplantation |
May be considered in the future for selected cases if the child survives and becomes medically eligible for transplantation. |
Important note: No medication should be administered, and no dosage should be determined, without the supervision of a specialized neonatal and pediatric nephrology team.
Serial amnioinfusion is not a drug treatment. It is an experimental intervention in which sterile fluid is repeatedly introduced into the amniotic sac under ultrasound guidance.
The aim is to replace amniotic fluid and attempt to improve the conditions required for fetal lung development. In some cases, this may help the fetus achieve sufficient lung growth to allow an attempt at respiratory support after birth.
However, several important considerations must be noted:
The procedure does not cause the kidneys to develop or restore their function.
It may be associated with complications, including infection, rupture of the membranes, and premature delivery.
It does not guarantee that the newborn will survive or that treatment after birth will be successful.
It should be considered at a specialized maternal-fetal medicine center within an appropriate research protocol or approved program.
If a baby is born with bilateral renal agenesis, the medical team may discuss the following options in highly selected cases:
Respiratory support: To provide oxygen and assist breathing, depending on the degree of lung development and the severity of respiratory impairment.
Peritoneal dialysis: May be used to replace some kidney functions if the infant's condition permits the procedure and the necessary medical resources are available.
Kidney transplantation: May be a future option if the child survives the critical period and meets the eligibility requirements for transplantation.
Palliative care: Aims to relieve pain, breathing difficulties, and discomfort while promoting the baby's comfort and supporting the family when life-sustaining interventions are not feasible or appropriate.
Bilateral congenital renal agenesis is a congenital abnormality in which both kidneys fail to develop during fetal growth. No surgical procedure can recreate kidneys that are absent from birth. However, certain surgical interventions may help replace some kidney functions in carefully selected cases, depending on the infant's respiratory condition and the stability of vital organ functions.
The choice of an appropriate intervention depends on when the condition is diagnosed and the clinical status of the fetus or newborn.
Placement of a peritoneal dialysis catheter is a surgical intervention that may be used to replace some kidney functions in children with complete kidney failure, including selected cases of bilateral renal agenesis, if their clinical condition permits.
This procedure does not treat the absence of the kidneys. Instead, it provides access for peritoneal dialysis, which helps remove waste products and excess fluid and regulate certain components of the blood.
The medical team evaluates the infant's weight, respiratory condition, and circulatory stability. The abdomen is examined, and the risks of infection and bleeding are assessed.
The procedure is performed under anesthesia or an appropriate form of sedation, depending on the newborn's condition. A pediatric surgeon inserts a specialized catheter into the peritoneal cavity, secures it, and brings its external portion through the abdominal wall.
The team checks that the catheter can safely deliver and drain dialysis fluid and confirms that there are no leaks or functional problems.
A pediatric nephrologist determines the type and volume of dialysis fluid, the duration it remains in the peritoneal cavity, and the number of dialysis cycles according to the infant's weight, clinical condition, and laboratory results.
Potential complications associated with catheter placement and peritoneal dialysis may include:
Catheter-related infection.
Leakage of dialysis fluid.
Catheter obstruction or displacement.
Bleeding or injury to surrounding structures.
Inadequate dialysis or difficulty tolerating the procedure.
Peritoneal dialysis may not be immediately feasible in some extremely small or medically unstable newborns. In such cases, the medical team must assess alternative methods of blood purification based on the resources available at the specialized center.
Kidney transplantation may be considered for a child who survives the critical period and becomes medically eligible for surgery. It offers a way to replace kidney function over the long term, but it is not an immediate option for every newborn affected by this condition.
The transplantation process involves assessing the child's suitability for surgery, identifying a suitable donor, performing the transplant, and providing close postoperative monitoring.
The child may need to continue dialysis after transplantation if the transplanted kidney takes time to begin functioning. Transplantation also requires lifelong medical follow-up and immunosuppressive medications according to the specialist team's instructions.
Recovery time varies according to the type of intervention and the child's health, particularly the degree of lung development and the stability of vital organ functions.
|
Procedure |
Expected recovery or monitoring period |
|---|---|
|
Serial amnioinfusion |
Monitoring after each session; hospitalization may be necessary depending on the clinical situation. |
|
Peritoneal dialysis catheter placement |
The period varies according to the infant's condition and catheter-site healing. A waiting period may be necessary before full dialysis begins. |
|
Initiation of peritoneal dialysis |
May begin early when necessary or after a waiting period determined by the treating team. |
|
Kidney transplantation |
Hospitalization may last a week or longer, depending on the response to treatment and the development of complications. |
|
Recovery after kidney transplantation |
May take several weeks to months, with continued medical follow-up and immunosuppressive medication. |
Important medical clarification: Bilateral renal agenesis is generally associated with a very poor prognosis because the absence of both kidneys causes complete loss of kidney function, while severe oligohydramnios can result in life-threatening pulmonary hypoplasia. Although experimental prenatal interventions and postnatal renal replacement therapies may be considered in highly specialized settings, their suitability depends on the individual case, and neither approach guarantees survival.
What's your complaint?